Quick Answer
Petros Pharmaceuticals, Inc. reported Shares Outstanding of 10.53 million shares for fiscal year 2024.
Petros Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 10.53M | +251.9% |
| 2023 | 2.99M | +43.9% |
| 2022 | 2.08M | +0.5% |
| 2021 | 2.07M | -78.7% |
| 2020 | 9.71M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 42.28M | +322.2% | +0.0% |
| June 30, 2025 | 42.28M | +354.8% | +1959.9% |
| March 31, 2025 | 2.05M | -70.2% | +387.4% |
| December 31, 2024 | 421,124 | -85.9% | -95.8% |
| September 30, 2024 | 10.01M | +372.5% | +7.7% |
| June 30, 2024 | 9.30M | +338.6% | +35.1% |
| March 31, 2024 | 6.88M | +229.5% | +130.1% |
| December 31, 2023 | 2.99M | +43.9% | +41.1% |
- Petros Pharmaceuticals, Inc. showed an increase of +251.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2024 period, Petros Pharmaceuticals, Inc.’s shares outstanding has grown by 8.5% (from 9.71 million shares to 10.53 million shares).
- The most recent figure is from Petros Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: